Olima Ventures

Olima Ventures is a smaller venture firm with a visible website, LinkedIn and Crunchbase presence but no disclosed healthcare thesis, sub-vertical focus, AI angle, geography or check size in the source data. Founders should treat Olima as a generalist early-stage candidate rather than a healthcare specialist. The firm is most likely deploying seed-stage checks, plausibly in the $100K to $1M range with limited reserve capacity to follow on aggressively, and is unlikely to lead competitive rounds at scale. Olima is most plausibly a fit for digital health, healthcare IT, B2B SaaS aimed at clinical or administrative buyers, and consumer-health businesses where standard venture pattern-matching applies and the founder owns the regulatory and clinical narrative. Therapeutics, regulated devices, diagnostics and any company that expects investor-driven hospital network access or payer relationships should look elsewhere. Founders raising for AI-driven healthcare products should be ready to lead diligence conversations on data sources, FDA pathway if relevant, and the realistic enterprise sales cycle, since the firm is unlikely to bring deep sector machinery. Entry is best attempted through LinkedIn outreach to named partners, ideally warmed by a mutual investor or portfolio founder, with a tight pitch focused on traction, ICP and capital efficiency rather than scientific narrative. In a first conversation, push for current fund size, deployment pace, average check, lead-versus-participant posture, and concrete examples of healthcare deals already in the portfolio to validate fit before investing significant pitching cycles.